Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.

@article{Yeung2004PharmacokineticsOO,
  title={Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.},
  author={Sharon M. Yeung and Scott E. Walker and Sandra A.N. Tailor and Linda Awdishu and Sheldon W Tobe and Teraiza Yassa},
  journal={Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis},
  year={2004},
  volume={24 5},
  pages={
          447-53
        }
}
BACKGROUND In order to avoid aminoglycosides, the International Society for Peritoneal Dialysis recommends cefazolin and ceftazidime for empirical treatment of peritonitis. Ciprofloxacin covers relevant gram-negative pathogens without the resistance associated with ceftazidime. However, ciprofloxacin pharmacokinetic data in patients on continuous cycling peritoneal dialysis (CCPD) are lacking. OBJECTIVES (1) To determine the pharmacokinetics of oral ciprofloxacin in CCPD patients, (2) to… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients

  • D Shermin, D Maaz, D St. Pierre, SI Kahn, JA. Chazan
  • Am J Kidney Dis
  • 1999
1 Excerpt

Similar Papers

Loading similar papers…